BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, February 3, 2026
Home » Authors » Anette Breindl

Articles by Anette Breindl

ApoE, tau interact directly in Alzheimer's disease

Sep. 25, 2017
By Anette Breindl
ApoE variants are the strongest known genetic risk factor not just for Alzheimer's disease (AD), but for any disease. It was first described just about 25 years ago. "And I've worked on it since then," David Holtzman told BioWorld.
Read More

Gene therapy scope broadens, again, with immune tolerance work

Sep. 22, 2017
By Anette Breindl
By delivering the gene for myelin oligodendrocyte glycoprotein (MOG), one of the proteins that is a frequent target of autoimmune attack in multiple sclerosis (MS), to the liver, researchers have been able to induce systemic immune tolerance. Depending on the timing of treatment, the approach could prevent or reverse the symptoms of even late-stage experimental autoimmune encephalitis (EAE), the mouse equivalent of MS.
Read More

Making lemonade: Zika virus kills glioblastoma stem cells

Sep. 21, 2017
By Anette Breindl

Zika virus kills glioblastoma stem cells in early research

Sep. 18, 2017
By Anette Breindl
Zika virus' greatest threat is its preference for developing brain cells. As a result, while infections in adults are mostly harmless – indeed, more often than not, they are asymptomatic – infections in pregnant women can have devastating effects on fetal brain development.
Read More

Bench Press: BioWorld looks at translational medicine

Sep. 18, 2017
By Anette Breindl
The most dangerous part of sepsis is not the phase of out-of-control inflammation, though that is plenty dangerous. It is the subsequent phase of immunosuppression, when septic individuals are highly susceptible to follow-on infections.
Read More

Genetics of depression yielding secrets, but diagnostic use a ways off

Sep. 13, 2017
By Anette Breindl and Omar Ford

Genetics of depression yielding secrets, but diagnostic use a ways off

Sep. 13, 2017
By Anette Breindl and Omar Ford
Looking at the prevalence data on depression is enough to set off depression in itself.
Read More

Bench Press: BioWorld looks at translational medicine

Sep. 11, 2017
By Anette Breindl
By considering information both from single cell types and across multiple cell types, scientists have been able to map the relationships of enhancers to gene expression levels in more than 900 different human primary cell types, tissue types and cell lines. Enhancers interact with promoters to regulate gene expression.
Read More

Microbiome bugs make GPCR-targeting drugs

Sep. 8, 2017
By Anette Breindl

2017 Lasker awards honor sexual health work and 'brain of the cell'

Sep. 7, 2017
By Anette Breindl

The 2017 Lasker Awards honored the discovery of the mTOR kinase by Michael Hall, the scientific groundwork that led to the development of the first preventive cancer vaccine by Douglas Lowy and John Schiller, and the women's health work done by Planned Parenthood.


Read More
Previous 1 2 … 143 144 145 146 147 148 149 150 151 … 400 401 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 3, 2025.
  • Today's news in brief

    Briefs
    BioWorld MedTech briefs for Jan. 30, 2026.
  • Centessa’s CNT-9982 shows promise for MDD

    BioWorld Science
    Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
  • Red and blue bispecific antibodies

    First-in-class ADC targeting DEM-TXX shows high preclinical efficacy

    BioWorld Science
    Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
  • Illustration of brain with neuron receptor

    5-HT2R allosteric ligands attenuate cocaine use and seeking behavior

    BioWorld Science
    Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing